Kenvue Inc. $KVUE Shares Sold by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its stake in Kenvue Inc. (KVUE) by 7.5%, now holding approximately 1.43 million shares valued at about $30 million.
• Kenvue's quarterly earnings showed an EPS of $0.29, exceeding estimates, but revenue fell by 4% year-over-year to $3.84 billion.
• The company increased its quarterly dividend to $0.2075, reflecting a dividend yield of 4.9% and a payout ratio of over 112%.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH trimmed its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 7.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,432,579 shares of the company's stock after selling 115,542 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH owned approximately 0.07% of Kenvue worth $29,984,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its stake in Kenvue by 4.9% during the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock worth $5,494,882,000 after acquiring an additional 10,600,682 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Kenvue by 2.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company's stock worth $613,882,000 after acquiring an additional 633,461 shares in the last quarter. Boston Partners grew its position in Kenvue by 7.4% during the 1st quarter. Boston Partners now owns 25,346,453 shares of the company's stock worth $606,920,000 after purchasing an additional 1,750,490 shares during the last quarter. JPMorgan Chase & Co. grew its position in Kenvue by 11.6% during the 1st quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company's stock worth $597,395,000 after purchasing an additional 2,597,920 shares during the last quarter. Finally, American Century Companies Inc. grew its position in Kenvue by 15.7% during the 1st quarter. American Century Companies Inc. now owns 21,828,854 shares of the company's stock worth $523,456,000 after purchasing an additional 2,961,716 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

KVUE has been the topic of several research reports. UBS Group lowered their price objective on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Zacks Research raised shares of Kenvue to a "strong sell" rating in a research report on Monday, August 11th. Barclays lowered their target price on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday, July 15th. JPMorgan Chase & Co. lowered their target price on shares of Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a report on Friday, July 25th. Finally, Evercore ISI lowered their target price on shares of Kenvue from $23.00 to $18.00 and set an "in-line" rating on the stock in a report on Tuesday. Four equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $23.32.

Kenvue Stock Performance

Shares of KVUE stock opened at $16.86 on Thursday. Kenvue Inc. has a one year low of $16.53 and a one year high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company has a 50 day moving average price of $20.59 and a 200 day moving average price of $21.93. The firm has a market capitalization of $32.35 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 2.48 and a beta of 0.83.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the prior year, the business posted $0.32 earnings per share. Kenvue's revenue for the quarter was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. Kenvue's payout ratio is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.